Blood Products Explained: Components and Transfusion Reactions
Compatibility clarification: AB plasma lacks the usual anti-A and anti-B antibodies. Type A plasma usually contains anti-B. Auto-captions at this point are ambiguous, so use this distinction for the plasma comparison.Source
What do red cells, platelets, plasma and cryoprecipitate replace?
Red cells increase oxygen-carrying capacity, platelets support the initial hemostatic plug, plasma replaces multiple clotting factors and cryoprecipitate supplies concentrated fibrinogen with selected proteins. These products solve different deficits. A higher hemoglobin does not establish corrected bleeding, compatible plasma follows different ABO logic from red cells, and suspected transfusion reactions require immediate assessment.
| Component | Main replacement | What it does not establish |
|---|---|---|
| Packed red cells | Red-cell mass and oxygen-carrying capacity | Correction of platelet or factor deficits |
| Platelets | Primary hemostatic platelet support | Correction of every coagulation abnormality |
| Plasma | Multiple clotting factors | A universal solution for an abnormal INR |
| Cryoprecipitate | Concentrated fibrinogen and selected proteins | Replacement of every plasma clotting factor |
Key takeaways
- Match the product to the missing function and the clinical setting.
- Red-cell compatibility and plasma compatibility involve opposite antigen-antibody directions.
- A unit means different quantities for red cells, pooled platelets and apheresis platelets.
- Bleeding, temperature, ionized calcium, potassium and perfusion need reassessment during major transfusion.
In this video
- Blood products: choose the component, then assess the patient
- What is in each blood-product bag?
- ABO, Rh and compatibility
- What one unit changes
- Platelet counts and transfusion context
- Plasma and the warfarin patient
- Cryoprecipitate and fibrinogen
- Working through the bleeding patient
- Recognizing transfusion reactions
- The potassium of 6.8
- Explaining transfusion decisions in an interview
- Practice questions
- Recap: component, patient and reassessment
- Keep learning with The CRNA Club
How do the blood components differ?
Packed red cells replace red-cell mass and increase oxygen-carrying capacity. They do not provide a therapeutic platelet dose or replace the whole coagulation system. Platelets support primary hemostasis. Plasma supplies multiple clotting factors, while cryoprecipitate concentrates fibrinogen and contains factor VIII, factor XIII and von Willebrand factor.
Whole blood combines red cells with plasma and platelets, but processing and storage affect the product. It is not interchangeable with every component ratio. A bleeding patient needs control of hemorrhage as well as replacement. Continued oozing despite a higher hemoglobin raises questions about platelets, clotting factors, fibrinogen, temperature and ionized calcium.
Why does ABO compatibility work differently for red cells and plasma?
For red cells, recipient antibodies must not attack donor red-cell antigens. Type O red cells lack A and B antigens but still carry other antigens. Antibody history, screening and crossmatching remain relevant even when ABO and RhD groups match.
For plasma, donor antibodies must be compatible with recipient red cells. AB plasma lacks the usual anti-A and anti-B antibodies. Type A plasma usually contains anti-B, so it must not be described as lacking both. Blood-bank emergency release policies account for the product, antibody titers and urgency. Emergency release does not replace patient identification or subsequent testing.
What does one unit change in the laboratory results?
In an average-sized nonbleeding adult, one red-cell unit commonly raises hemoglobin by about 1 g/dL. Active hemorrhage, dilution, hemolysis and patient size alter that estimate. A platelet unit from one whole-blood donation is a smaller quantity than a pooled adult dose or an apheresis dose.
The response to cryoprecipitate also depends on fibrinogen content, plasma volume, recovery and continued consumption. A bag count does not establish an indication or predict a guaranteed increment. Use the actual component labeling, expiration and blood-bank instructions rather than treating every product called one unit as equivalent.
Why do platelet thresholds depend on the procedure and the patient?
A platelet count must be interpreted with bleeding, platelet function, the reason for thrombocytopenia and procedural risk. The 2025 AABB/ICTMG guidance uses different thresholds for defined populations. Major nonneuraxial surgery is a different setting from an epidural, lumbar puncture or a nonbleeding patient receiving chemotherapy.
One numerical cutoff does not guarantee hemostasis. Cardiopulmonary bypass and extracorporeal circuits change platelet function and consumption, but do not establish that every patient requires prophylactic platelets. Neuraxial decisions also depend on the cause and trend of the platelet abnormality and other bleeding risks.
What should you assess when a reaction or electrolyte problem occurs?
For a suspected transfusion reaction, stop the transfusion and assess airway, breathing and circulation while obtaining urgent help and notifying the blood bank. Preserve access using the appropriate reaction process without flushing suspect blood into the patient. Fever is not automatically a benign febrile reaction. Hemolysis, contamination and other serious causes require consideration.
Circulatory overload and transfusion-related acute lung injury both cause hypoxemia and pulmonary edema, but their mechanisms differ. Citrate also binds ionized calcium, while stored red cells contribute potassium. Check sample quality and repeat an unexpectedly hemolyzed potassium promptly without delaying emergency assessment. Calcium supports cardiac membrane stability in hyperkalemia but does not remove potassium.
